Objectives : Toevaluateandsummarizetheefficacyandsafetyofacupuncturetreatment(AT) inchronicfatiguesyndrome(CFS).
Ⅰ. Introduction
Chronic fatigue syndrome (CFS) results in an unexplained fatigue that lasts for more than 6 months and is accompanied by various symptoms such as memory and concentration losses, postexercise fatigue, sleep disorder, depression, and anxiety. Diagnostic criteria such as those of the Centers for Disease Control and Prevention (CDC; 1988) 1) , CDC (1994) 2) , Australian criteria 3) , and British criteria 4) have been officially used. Among these, Fukuda' s CDC (1994) criteria were the most widely used. According to Wessely' s study where the literature related to CFS in several countries was reviewed, the prevalence of chronic fatigue was 7-21%, and the prevalence of patients who met the criteria for CFS was 0.5-2% 5) . In a prospective study of patients who visited a primary medical clinic, 1.2-2.6% of them were diagnosed with CFS; in particular, the patients who met the CDC (1994) criteria were 2.6% 6) . In general, the prevalence rate of CFS is reported to be 1-2%.
The cause and mechanism of CFS are so far unclear, and to date there is no officially recognized treatment. In Cochrane-Reviews, several systematic reviews on exercise therapy 7) , cognitive behavior therapy 8) , and herbal medicine treatment 9) have been reported. Furthermore, oriental medicine treatment 10) and complementary and alternative medicine (CAM) therapies have also been reported 11) . However, no studies on acupuncture and CFS have been reported since the systematic review in China in 2009 12) , in which studies pub- Therefore, the purpose of the present review was to assess the efficacy and safety of AT by systematically summarizing data from randomized controlled trials (RCTs) of acupuncture in patients with CFS.
Ⅱ. Methods
1.Search methods
We searched the following 15 references from previous systematic reviews were also searched.
The following keywords were used for the search and were adjusted for each database: ( "chronic fatigue syndrome" OR"myalgic encephalomyelitis"
OR "myalgic encephalitis" ) AND ( "acupuncture" OR "electroacupuncture" OR"pharmaco-acupuncture" OR "acupressure" OR "acupoints" OR "acupoint injection" OR "dry needle" OR "needling" ). The details are described in Appendix 1.
2.Study selection 1)Types of studies
We included all relevant RCTs and quasi-RCTs of any type of AT regardless of the study design, published language, number of participants, and blinding. Observational, uncontrolled, casecontrol, case series and laboratory studies were excluded.
2)Types of patients
Patients who were diagnosed by any defined diagnosis criteria of CFS such as CDC, Australian and British criteria were included regardless of sex, age, race, disease course, and severity. 
3)Types of interventions

4)Types of outcome measures
We extracted the data of each measured outcome at the end of the treatment. The outcomes were divided into primary and secondary outcomes.
(1 
5)Data extraction and quality assessment
Two independent reviewers participated in the process of literature search, selection, and data ex- Ⅲ. Results
1.Study selection and description
A total of 1,277 studies were screened and 869 participants of 11 RCTs were finally included in this review. Fig. 1 selection process.
Among the 11 studies, nine were conducted in China [13] [14] [15] [18] [19] [20] [21] [22] [23] , one was in Hong Kong 16) , and one was in Korea 17) . The number of participants included in each study ranged between 17 and 157, with a mean age of 38.0 years and a men-towomen ratio of 1:1.5. The CDC criteria were used for diagnosis in all studies; one study used the 1988 CDC criteria 13) , while the other 10 studies used the 1994 CDC criteria (Fukuda criteria). Moreover, the FS was the most commonly used primary outcome 13, 15, 16, [19] [20] [21] , while FSS was used in four studies 17, 18, 22, 23) . As secondary outcomes, SF-36 was used in four studies 14, 18, 22, 23) , SPHERE in four 14, 18, 22, 23) , WHOQOL-BREF in two 20, 21) , and various scales were used in each study (Table 1 ).
2.Interventions 1)Classification
The study design was classified into three categories based on the intervention in the control group. Among the 11 RCTs, nine studies [14] [15] [16] [18] [19] [20] [21] [22] [23] were compared with Sham acupuncture, while the other two studies were compared to the Wait-list group 17) and Western medication group 13) .
2)General characteristics of acupuncture treatment(Appendix2)
(1) Types of acupuncture treatment
Among the 12 groups of the 11 selected studies, simple AT was used in nine groups [13] [14] [15] [16] [17] [18] [19] [20] [21] , electroacupuncture was used in two 22, 23) , and moxaheated needling was used in one 15) .
(2) Acupoints and meridians A total of 21 acupoints were used. The most used acupoint was ST36, which was applied in eight studies [14] [15] [16] 18, [20] [21] [22] [23] , followed by BL23 in seven studies 13, 14, 17, 18, [21] [22] [23] , BL18 13, 14, 17, 18, 21) and GV20 in five studies [14] [15] [16] [17] 21) , BL15 13, 17, 19) , BL20 17, 19, 21) , CV4 13, 15, 21) , CV6 13, 15, 21) , CV17 13, 15, 21) , and SP6 15, 16, 21) in three studies, CV12 13, 21) , HT714,18), LI4 15, 21) , LR3 15, 21) , KI3 20, 21) in two studies, and BL11 17) , BL13 17) , BL17 13) , BL22 13) , BL43 19) , and GB20 17) in one study.
The Bladder meridian was the most used meridian (nine acupoints in eight studies 13, 14, [17] [18] [19] [21] [22] [23] ), followed by Conception extra meridian (four acupoints in three studies 13, 15, 21) ), Stomach meridian (one acupoint in eight studies [14] [15] [16] 18, [20] [21] [22] [23] ), Governor extra meridian (one acupoint in five studies [14] [15] [16] [17] 21) ),
Spleen meridian (one acupoint in three studies 15, 16, 21) ), Large Intestine meridian 15, 21) , Gall
Bladder meridian 17) (one acupoint in one study), and Liver meridian 15, 21) , Heart meridian 14, 18) , and Kidney meridian 20, 21) (one acupoint in two studies).
(3) Treatment methods
In seven of the 11 RCTs [13] [14] [15] [16] 18, 20, 21) , the retaining time of AT was 30 minutes, while it was 20 minutes in the remaining four studies 17, 19, 22, 23) .
De-Qi was performed in eight studies [14] [15] [16] [18] [19] [20] [21] [22] , while one study 17) did not perform it, and the remaining two studies 13, 23) did not describe it.
3.Risk of bias
The quality of the literature was evaluated by using the Cochrane risk of bias tool ( Fig. 2 and 3 ).
All the selected studies used randomization methods, but only eight RCTs [14] [15] [16] [17] [18] 20, 21, 23) presented a detailed methodological description, while the remaining three 13, 19, 22) did not. Three RCTs 17, 21, 23) adequately performed the allocation concealment, which was not described in the remaining studies [13] [14] [15] [16] [18] [19] [20] 22) . Because of the nature of the AT, the practitioners cannot be blinded during the treatment.
Therefore, all the included studies had a high risk of performance bias. The blinding of the evaluator was reported in six RCTs 14, [17] [18] [19] 21, 23) , while four RCTs 13, 15, 20, 22) did not, and one 16) implemented it inadequately. Six RCTs [17] [18] [19] [21] [22] [23] fully reported the reasons for dropouts and withdrawals, while two RCTs 16, 20) involving dropouts did not describe the reasons, and the remaining three RCTs [13] [14] [15] did not involve any dropouts. Only one study 17) had a pro-tocol that was followed adequately. Out of the 11
RCTs, there were no baseline differences in 10 trials, while the remaining study 15) did not present the baseline data, and had thus a high risk of potential bias.
4.Summary of the main results
The efficacy of AT was analyzed in the following three categories: Acupuncture vs Sham acupuncture, Acupuncture vs Wait-list, and Acupuncture vs Western medicine treatment ( Table 2 , 3, and 4).
1)Acupuncture vs Sham acupuncture
(1) Fatigue
Both the FS and FSS were used as outcome variables. Three RCTs 16, 20, 21) using the FS in the same study design were included in the meta-analysis and showed a significant fatigue reduction effect compared with the Sham acupuncture group ( Among five RCTs using SF-12 16) , SF-20 19) , and SF-36 14, 18, 22) , two studies 19, 22) reported a significant improvement compared with the control group (SMD 1.22; IV, Random; 95% CI, 0.82 to 1.61 / SMD 1.84; IV, Random; 95% CI, 1.23 to 2.45). However, there were no significant differences between the two groups in the remaining three studies 14, 16, 18) . In one 14) of the studies, the effect of improving the quality of life was higher in the Sham acupuncture group, although not statistically significant. Metaanalysis was not performed due to the unexplained high heterogeneity (I 2 = 89%). Wang et al 23) was excluded from the quantitative synthesis because of insufficient data.
Three RCTs using WHOQOL-BREF 20, 21) and GHQ-12 16) were quantitatively synthesized and indicated no significant difference between the two groups ( TheAcupunctureVol.34No.2May2017 2)Acupuncture vs Wait-list 
3)Acupuncture vs Western medicine treatment (1) Fatigue
In one RCT 13) , AT was compared with Western medication treatment and FS was used as outcome variable. There was a significant fatigue reduction effect compared with the Western medicine group (n = 157; MD, -2.83; IV; Fixed; 95% CI, -3.18 to -2.48; p < 0.00001).
(2) Quality of life, pain, and mood disorder
The quality of life, pain, and mood disorder were not reported in comparing AT to the Western medication group.
4)Safety
Nine (81.8%) out of the 11 RCTs 13, [15] [16] [17] [18] [19] [20] [21] 23) reported adverse events (Table 1) . Among these nine studies, there were only two cases of mild subcutaneous hemorrhage in Zhang et al. 18) , but the group to which these cases belonged to was not reported.
No other adverse events were reported in the remaining eight studies 13, [15] [16] [17] [19] [20] [21] 23) .
Ⅳ. Discussion
The CFS is a group of symptoms accompanied by severe fatigue, cognitive decline, pain, and insomnia 2) . There are no definite diagnosis methods and the causes of CFS remain unclear. Therefore, various treatments are currently used to alleviate the fatigue and improve the quality of life 17, 24) .
In recent studies comparing individuals with CFS to healthy controls, the involvement of the central nervous system, neuro-hormone control system, chronic immune activity, and psycho-social factors has been reported 24) . Based on this, a variety of therapies such as exercise 7) , behavioral therapy 8) , and CAM [9] [10] [11] [12] have been studied.
In particular, several studies [25] [26] [27] [28] [29] have shown that AT is also effective in relieving fatigue. In the reactive oxygen mechanism, AT increases superoxide dismutase (SOD) and glutathione peroxidase (GSH-PX), and decreases malonaldehyde (MDA) 25, 26) . Furthermore, AT increases the lactate dehydrogenase (LDH), decreases creatine kinase (CK) 27) , enhances the muscle function by participating in Ca
2+
-ATPase activity in skeletal muscle cells 28) , and activates the neuro-endocrineimmune system by controlling the hypothalamuspituitary-adrenal axis and the immune system 29) .
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Although studies about the mechanism of acupuncture in reducing fatigue exist, there is no systematic review of acupuncture since 2009. In addition, there were several limitations in the previous review 12) . Therefore, we attempted to systematically summarize the efficacy and safety of AT.
A total of 1,277 studies were selected by searching 15 domestic and overseas databases. Finally, 11 RCTs with 869 patients with CFS were included and analyzed.
First, nine RCTs [14] [15] [16] [18] [19] [20] [21] [22] [23] compared between AT and Sham acupuncture and demonstrated a statistically significant effect of AT in relieving fatigue and pain, but not in improving the quality of life and mood ( Table 2 ). The evidence was unclear in the analysis of quality of life possibly due to the lack of consistency in the reported results, wide range of confidence intervals, small sample size, and the small number of studies that evaluated mood disorders such as depression and anxiety (i.e., one study 21) ).
Second, one RCT 17) compared between AT and patients in the Wait-list group and showed a significant effect of AT in alleviating fatigue and mood disorders including stress response, depression, and insomnia; the results were not conclusive due to the low number of studies (Table 3) .
Finally, one RCT 13) compared between AT and Western medication and also showed a significant fatigue reducing effect of AT. This evidence was also inconclusive due to the low number of studies (Table 4) .
Nine (81.8%) of the 11 RCTs1 3, [15] [16] [17] [18] [19] [20] [21] 23) reported adverse events, but there were no serious adverse cases except for two 18) with mild subcutaneous hemorrhage.
The previous systematic review 12) of AT in CFS also reported a significant effect of AT in alleviating the symptoms, but the search period was limited to the period between 1998 and 2008. ing bias because only one study 15) presented a study protocol. Fifth, nine of the 11 selected studies [13] [14] [15] [18] [19] [20] [21] [22] [23] were conducted in China; thus there was a possibility of potential bias in publishing. ). c There is no high risk of bias, but several domains are unclear. d Although there is a heterogeneity, two studies have same effect for alleviating fatigue. e The I2 score is large and heterogeneity is significant, but the heterogeneity is explained by subgroup analysis and all studies have a consistency of MD. f One study has a high risk of detection bias and incomplete outcome data bias, and other studies are unclear in several domains. g Unexplained heterogeneity (I 2 =90.5%) and there is no consistency of SMD. h The CIs encompass benefit and harm. I Only one study included and total sample size is relatively small. In addition, the CIs are wide and encompass benefit and harm. In future systematic reviews, more welldesigned RCTs should be included in the final selection. Hence, the study design of each RCT including intervention and control group settings, random sequence generation, allocation concealment, blinding of patients and evaluators, and preprotocol study registration should be made appropriately. In addition, in order to obtain a more clear evidence from the meta-analysis, larger studies should be included and unexplained heterogeneity should be minimized in the quantitative synthesis by additional subgroup analysis according to the study design. Moreover, future studies should standardize the outcome variables for the same symptom to reduce the heterogeneity.
Ⅴ. Conclusion
This review established evidence that AT in patients with CFS may be beneficial in alleviating the symptoms, and showed that there are no indications of symptom deterioration or serious adverse events. A positive effect on fatigue and pain was also observed, but no conclusion regarding improvement in the quality of life and mood disorders could be drawn.
